Moderna Inc at Morgan Stanley Global Healthcare Conference Transcript
Great. Well, good afternoon, everybody. Thanks for joining us. I'm Terence Flynn, the U.S. biopharma analyst at Morgan Stanley. We're very pleased to be hosting Moderna this afternoon. We have Stephane Bancel, who is the company's CEO. Stephane, thanks so much for being here.
Before we get started, for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. Stephane, thanks so much again for your time today. Really looking forward to catching up again as it's been a while, as we were just talking about before.
Questions & Answers
Maybe I thought the place to start, just high level, give us an update on kind of strategic focus for the company here and capital allocation priorities as obviously, we're shifting to this kind of post-pandemic world here
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |